Agenus Inc (AGEN:NAS): Analytics, Extensive Financial Metrics, and
Benchmarks Against Averages and Top Companies Within its Industry
Key Findings: - Unique new report provides deep financial benchmarks for (Agenus Inc (AGEN:NAS) compared to its top competitors and compared to the average for all companies within its primary industry. - Benchmarking study for (Agenus Inc ) includes growth forecast for its primary industry to the year 2024. The purpose of this report is to provide vital corporate-specific benchmarks, comparing the Subject Company to its top competitors (on a company-by-company basis) and to the averages within its primary industry for all key metrics. This is a unique report containing high-value data. The report begins with a superb overview of the primary industry of the Subject Company, including historical industry revenues, revenue forecasts and CAGR. Then the report moves into industry averages and metrics, then into data specific to the Subject Company, with comparative data for the Subject Company’s top competitors. This report will save countless hours of research and analytical work for the end user.
Core Benefits to Customer: 1) Comprehensive benchmarks for the Subject Company: a. Benchmarked against the leading firms in its primary industry b. Benchmarked against the average for publicly-held companies (U.S.) in its industry. c. This includes financial results, ratios, vital statistics and metrics in one package, including historical and current metrics and averages for 6 years within its primary industry. 2) A snapshot overview of the company’s primary industry, including current and historic revenues and employment, along with a long term forecast for industry growth, with CAGR (compound annual growth rate), employee population and much more. 3) Detailed rankings of the Subject Company against top companies within the industry (U.S.-based firms) for key items including: a. Approximate market capitalization b. Employees c. Revenues d. Net income e. 3-Year revenue growth (%) f. 3-Year income growth (%) g. Return on assets (%) h. Return on equity (%) i. Return on invested capital (%) 4) Leading companies-profiles of the Subject Company as well as profiles of top competitors within the industry Pages: 84 Statistical Tables Provided: 28 Charts Provided: 14 Geographic: US This report is part of the Plunkett’s Corporate
Benchmarks series, published by the Plunkett Analytics unit of Plunkett Research, Ltd.
Designed to benefit: - Analysis and Financial Modeling -Investment Professionals - Lenders - M&A Advisors - Appraisers - Consultants
Companies Profiled: - Johnson & Johnson - Procter & Gamble Co - Pfizer Inc - Dow Chemical Company (The) - Merck & Co Inc - Gilead Sciences Inc - AbbVie Inc - DuPont (E I du Pont de Nemours & Co) - ExxonMobil Chemical - Amgen Inc
Our reports have been used by over 10K customers, including:
198 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Global Polyethylene Glycol Market to Reach $8.4 Billion by 2027
- Amid the COVID-19 crisis, the global market for Polyethylene Glycol estimated at US$4.5 Billion in the year 2020, is projected to reach a revised size of US$8.4 Billion by 2027, growing at a CAGR of 9.4% over the analysis period 2020-2027....
Readers of one of the analyst’s media partners were invited to participate in an online survey in September 2020 that centered on the state of their laboratories in 2020 and their expectations for 2021.The analyst has conducted similar studies among the same targeted respondents since 2012.
Where applicable, the study presents year-over-year...
The Global Data Historian Market is poised to grow at a CAGR of around XX% over the next decade to reach approximately $XX million by 2028. Some of the prominent trends that the market is witnessing include increasing demand for consolidated data for process and performance improvement, growing need for industrial 360...
191 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Global Dimethylformamide (DMF) Market to Reach $820.6 Million by 2027
- Amid the COVID-19 crisis, the global market for Dimethylformamide (DMF) estimated at US$669.5 Million in the year 2020, is projected to reach a revised size of US$820.6 Million by 2027, growing at a CAGR of 2.9% over the analysis period...
182 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Global 2,5-Furandicarboxylic Acid (FDCA) Market to Reach $521.8 Million by 2027
- Amid the COVID-19 crisis, the global market for 2,5-Furandicarboxylic Acid (FDCA) estimated at US$325.3 Million in the year 2020, is projected to reach a revised size of US$521.8 Million by 2027, growing at a CAGR of 7% over...
143 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Global Animal Blood Plasma Products and Derivatives Market to Reach $1.8 Billion by 2027
- Amid the COVID-19 crisis, the global market for Animal Blood Plasma Products and Derivatives estimated at US$1.2 Billion in the year 2020, is projected to reach a revised size of US$1.8 Billion by 2027, growing at...
185 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Global Microfluidic Device Systems Market to Reach $10.7 Billion by 2027
- Amid the COVID-19 crisis, the global market for Microfluidic Device Systems estimated at US$3.1 Billion in the year 2020, is projected to reach a revised size of US$10.7 Billion by 2027, growing at a CAGR of 19.6% over the analysis...
372 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Global Closed System Transfer Devices Market to Reach $1.6 Billion by 2027
- Amid the COVID-19 crisis, the global market for Closed System Transfer Devices estimated at US$457 Million in the year 2020, is projected to reach a revised size of US$1.6 Billion by 2027, growing at aCAGR of 19.4% over the period...
396 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Global Pharmaceutical Filtration Market to Reach $43.1 Billion by 2027
- Amid the COVID-19 crisis, the global market for Pharmaceutical Filtration estimated at US$21.1 Billion in the year 2020, is projected to reach a revised size of US$43.1 Billion by 2027, growing at a CAGR of 10.8% over the analysis...
176 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Global Carglumic Acid Market to Reach $167.4 Million by 2027
- Amid the COVID-19 crisis, the global market for Carglumic Acid estimated at US$109.3 Million in the year 2020, is projected to reach a revised size of US$167.4 Million by 2027, growing at aCAGR of 6.3% over the period 2020-2027. Tablet, for...
Pharmaceutical
Biopharmaceutical
World
China
United States
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.